Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide and U-500 regular insulin in very insulin-resistant obese adults with type 2 diabetes
PACTR201308000617367Completed
- Sponsor
- DistillerSR
- Start
- Sep 2011
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of exenatide and insulin regular human U-500 in type 2 diabetes mellitus (T2DM), sponsored by DistillerSR. Started Sep 2011; status: completed.
02
Drugs
exenatideinsulin regular human U-500
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on PACTR201308000617367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201308000617367.